These findings suggest that the risk of exposure to primaquine among people infected with P. vivax might be lower than previously assumed, because G6PD deficiency is less common among P. vivax-infected patients than among the general population. The gene discussed is G6PD; the disease is hyperinsulinemic hypoglycemia, familial, 4.